Skip to main content
Egyptian Liver Journal

Table 8 Correlation between and baseline carotid IMT and other risk factors

From: Assessment of carotid atherosclerosis in Egyptian chronic hepatitis C patients after treatment by direct-acting antiviral drugs

 

Carotid IMT

r

p-value

Age

0.612

 < 0.001*

BMI

0.263

.019*

Systolic BP

0.128

0.257

Diastolic BP

.031

0.782

Pulse

.023

0.837

Hb

 − 0.400

 < 0.001*

WBCs

 − .083

0.466

Platelets

 − 0.638

 < 0.001*

ALT

.054

0.632

AST

.047

0.678

Albumin

 − 0.790

 < 0.001*

Bilirubin

0.782

 < 0.001*

INR

0.352

0.001*

CTP score

0.846

 < 0.001*

HCV RNA

.088

0.437

TC

0.357

0.001*

TGs

 − 0.129

0.254

LDL

 − .070

0.539

HDL

 − 0.418

 < 0.001*

S. creatinine

 − .062

0.586

Urea

 − .052

0.647

RBS

.002

0.989

AFP

.092

0.417

Carotid plaques

0.290

0.009

  1. p ≤ 0.05 is considered statistically significant; p ≤ 0.01* is considered highly statistically significant. In non-SVR patients, there was no statistically significant difference in total cholesterol, triglycerides, LDL, and HDL at baseline and follow-up (p > 0.05), while in SVR group, total cholesterol, triglycerides, LDL, and HDL were significantly increased after follow-up compared to baseline (p < 0.001). It was noticed that LDL was significantly higher in SVR group compared to non-SVR after treatment (p = 0.034). Also, carotid IMT was significantly lower in SVR group compared to non-SVR (p = 0.016)
Back to article page